Global Blood Plasma Derivatives Market Research Report 2019 (Includes Business Impact of COVID-19)

  • TBI593588
  • March 20, 2019
  • Global
  • 105 pages
  • QY Market Research

Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used. The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market. The global Blood Plasma Derivatives market is valued at 24800 million US$ in 2018 is expected to reach 52000 million US$ by the end of 2025, growing at a CAGR of 9.7% during 2019-2025. This report focuses on Blood Plasma Derivatives volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Plasma Derivatives market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Grifols SK Plasma Fusion Health Care Biotest AG Green Cross Corporation Baxter International LFB Octapharma AG CSL Limited Shire Plc. China Biologic Products Kedrion Biopharma BDI Pharma Bayer AG Hualan Biological Engineering Segment by Regions North America Europe China Japan Segment by Type Albumin Factor VIII Factor IX Immunoglobulin Hyperimmune Globulin Others Segment by Application Hospitals Clinics Other End Users

Table of Contents

Executive Summary
1 Blood Plasma Derivatives Market Overview
    1.1 Product Overview and Scope of Blood Plasma Derivatives
    1.2 Blood Plasma Derivatives Segment by Type
        1.2.1 Global Blood Plasma Derivatives Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Albumin
        1.2.3 Factor VIII
        1.2.4 Factor IX
        1.2.5 Immunoglobulin
        1.2.6 Hyperimmune Globulin
        1.2.7 Others
    1.3 Blood Plasma Derivatives Segment by Application
        1.3.1 Blood Plasma Derivatives Consumption Comparison by Application (2014-2025)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other End Users
    1.4 Global Blood Plasma Derivatives Market by Region
        1.4.1 Global Blood Plasma Derivatives Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Blood Plasma Derivatives Market Size
        1.5.1 Global Blood Plasma Derivatives Revenue (2014-2025)
        1.5.2 Global Blood Plasma Derivatives Production (2014-2025)

2 Global Blood Plasma Derivatives Market Competition by Manufacturers
    2.1 Global Blood Plasma Derivatives Production Market Share by Manufacturers (2014-2019)
    2.2 Global Blood Plasma Derivatives Revenue Share by Manufacturers (2014-2019)
    2.3 Global Blood Plasma Derivatives Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Blood Plasma Derivatives Production Sites, Area Served, Product Types
    2.5 Blood Plasma Derivatives Market Competitive Situation and Trends
        2.5.1 Blood Plasma Derivatives Market Concentration Rate
        2.5.2 Blood Plasma Derivatives Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Blood Plasma Derivatives Production Market Share by Regions
    3.1 Global Blood Plasma Derivatives Production Market Share by Regions
    3.2 Global Blood Plasma Derivatives Revenue Market Share by Regions (2014-2019)
    3.3 Global Blood Plasma Derivatives Production, Revenue, Price and Gross Margin (2014-2019)
| 

Request a sample

Fill below form to request a sample


Please fill this form to enquire before buying


You can request for discount regarding the report by using below form